Literature DB >> 17928310

Smoking is associated with an age-related decline in exhaled nitric oxide.

J S Sundy1, D W Hauswirth, S Mervin-Blake, C A Fernandez, K B Patch, K M Alexander, S Allgood, P D McNair, M C Levesque.   

Abstract

Age-related declines in forced expiratory volume in one second are accelerated in smokers. Smoking is associated with decreased exhaled nitric oxide fraction (F(eNO)). The aim of the present study was to determine the impact of age on F(eNO) in otherwise healthy smokers and nonsmokers. F(eNO) and serum cotinine levels were measured in 994 healthy subjects aged 18-40 yrs. American Thoracic Society questionnaire data on smoking habits was used to validate serum cotinine levels as a surrogate marker for categorisation of smokers and nonsmokers in the cohort. Serum cotinine levels were a good discriminator of smokers (n = 99) and nonsmokers (n = 895). F(eNO) levels were significantly lower in otherwise healthy smokers compared with nonsmokers. There was an inverse correlation of serum cotinine levels with F(eNO). No correlation of age with F(eNO) was found in nonsmokers but an inverse correlation of F(eNO) with age in smokers was found. F(eNO) was significantly lower in smokers aged 21-40 yrs compared with nonsmokers aged 21-40 yrs, but was not lower in smokers aged 18-20 yrs compared with nonsmokers of the same age. Smoking was associated with decreased exhaled nitric oxide. The greatest smoking-related declines in exhaled nitric oxide occurred in older subjects. This suggests that smoking is associated with age-related declines in exhaled nitric oxide and justifies future mechanistic studies that address the impact of exhaled nitric oxide decline on lung function.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17928310     DOI: 10.1183/09031936.00087807

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  5 in total

1.  Nitrite in exhaled breath condensate as a marker of nitrossative stress in the airways of patients with asthma, COPD, and idiopathic pulmonary fibrosis.

Authors:  Vladimír Rihák; Petr Zatloukal; Jirina Chládková; Alena Zimulová; Zuzana Havlínová; Jaroslav Chládek
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

2.  Exhaled nitric oxide in asthma: progress since the introduction of standardized methodology.

Authors:  Natalia M Grob; Raed A Dweik
Journal:  J Breath Res       Date:  2008-09       Impact factor: 3.262

3.  Effects of atopy and rhinitis on exhaled nitric oxide values - a systematic review.

Authors:  Daniela Linhares; Tiago Jacinto; Ana M Pereira; João A Fonseca
Journal:  Clin Transl Allergy       Date:  2011-08-17       Impact factor: 5.871

4.  Factors Influencing the Concentration of Exhaled Nitric Oxide (FeNO) in School Children Aged 8-9-Years-Old in Krakow, with High FeNO Values ≥ 20 ppb.

Authors:  Marta Czubaj-Kowal; Grzegorz Józef Nowicki; Ryszard Kurzawa; Maciej Polak; Barbara Ślusarska
Journal:  Medicina (Kaunas)       Date:  2022-01-18       Impact factor: 2.430

5.  COPD phenotype description using principal components analysis.

Authors:  Kay Roy; Jacky Smith; Umme Kolsum; Zöe Borrill; Jørgen Vestbo; Dave Singh
Journal:  Respir Res       Date:  2009-05-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.